Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Wolff

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
The American Journal of Medicine|August 1, 1983
Neoplastic meningitis. Marked variations of cerebrospinal fluid composition in the absence of extradural blockJ J Murray, F A Greco, S N Wolff, et al.
Journal of Cellular Biochemistry|January 1, 1983
Antigens in chromatin associated with proliferating and nonproliferating cellsR C Briggs, G Brewer, A Goldberger, et al.
Leukemia & Lymphoma|September 1, 1996
Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: a pilot studyR S Stein, J P Greer, J M Flexner, et al.
Bone Marrow Transplantation|November 1, 1988
Use of the BCR probe to demonstrate extramedullary recurrence of CGL with a T cell lymphoid phenotype following bone marrow transplantationL Giannone, J A Whitlock, M C Kinney, et al.
Experimental Hematology|January 1, 1979
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) autologous bone marrow transplantation therapy of refractory cancer: a preliminary reportG L Phillips, J W Fay, G P Herzig, et al.
Clinical Pharmacology and Therapeutics|May 1, 1982
Effects of high-dose cytarabineK R Hande, R S Stein, D A McDonough, et al.
Cancer Treatment Reports|October 1, 1983
High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lungS N Wolff, D H Johnson, K R Hande, et al.
Seminars in Oncology|June 1, 1985
Central nervous system toxicity with high-dose cytosine arabinosideR H Herzig, H M Lazarus, G P Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemiaR H Herzig, H M Lazarus, S N Wolff, et al.
Cancer Treatment Reports|July 1, 1985
High-dose cytarabine for the treatment of blastic phase chronic myelogenous leukemiaR H Herzig, G L Phillips, H M Lazarus, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
The American Journal of Medicine|August 1, 1983
Neoplastic meningitis. Marked variations of cerebrospinal fluid composition in the absence of extradural blockJ J Murray, F A Greco, S N Wolff, et al.
Journal of Cellular Biochemistry|January 1, 1983
Antigens in chromatin associated with proliferating and nonproliferating cellsR C Briggs, G Brewer, A Goldberger, et al.
Leukemia & Lymphoma|September 1, 1996
Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: a pilot studyR S Stein, J P Greer, J M Flexner, et al.
Bone Marrow Transplantation|November 1, 1988
Use of the BCR probe to demonstrate extramedullary recurrence of CGL with a T cell lymphoid phenotype following bone marrow transplantationL Giannone, J A Whitlock, M C Kinney, et al.
Experimental Hematology|January 1, 1979
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) autologous bone marrow transplantation therapy of refractory cancer: a preliminary reportG L Phillips, J W Fay, G P Herzig, et al.
Clinical Pharmacology and Therapeutics|May 1, 1982
Effects of high-dose cytarabineK R Hande, R S Stein, D A McDonough, et al.
Cancer Treatment Reports|October 1, 1983
High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lungS N Wolff, D H Johnson, K R Hande, et al.
Seminars in Oncology|June 1, 1985
Central nervous system toxicity with high-dose cytosine arabinosideR H Herzig, H M Lazarus, G P Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemiaR H Herzig, H M Lazarus, S N Wolff, et al.
Cancer Treatment Reports|July 1, 1985
High-dose cytarabine for the treatment of blastic phase chronic myelogenous leukemiaR H Herzig, G L Phillips, H M Lazarus, et al.
Pageof 10